These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2659241)

  • 21. Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish Reference Group for Antibiotics (SRGA and SRGA-M).
    Olsson-Liljequist B; Forsgren A
    Scand J Infect Dis Suppl; 1997; 105():5-7. PubMed ID: 9435025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standardization of laboratory tests for tuberculosis and their proficiency testing].
    Abe C
    Kekkaku; 2003 Aug; 78(8):541-51. PubMed ID: 14509226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of resistance testing in clinical trial design and product labelling: a regulatory perspective.
    Laessig KA; Murray JS; Chikami G
    Antivir Ther; 2000 Mar; 5(1):77-83. PubMed ID: 10846597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of effectiveness of a continuing education program on antimicrobial susceptibility testing.
    Rosner ER; Mulawski KK; Willis JR; Lipman HB; Boone AS; Hindler JF
    Clin Lab Sci; 2007; 20(3):146-53. PubMed ID: 17691670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardization of susceptibility testing methods.
    Phillips I; King A
    J Chemother; 1997 May; 9 Suppl 1():13-8. PubMed ID: 9248958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial spectrum of an antibiotic and clinical categorization].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The identification and antimicrobial susceptibility testing of Neisseria gonorrhoeae, 1980-1987. Results from the College of American Pathologists Microbiology Surveys Program.
    Jones RN; Edson DC
    Arch Pathol Lab Med; 1988 May; 112(5):485-8. PubMed ID: 3128961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standardization in clinical laboratory--its national and international activities].
    Kawai T
    Rinsho Byori; 1993 Apr; 41(4):340-4. PubMed ID: 8350495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Consensus for antimicrobial susceptibility testing for Enterobacteriaceae. Subcommittee on Antimicrobials, SADEBAC (Argentinian Society of Clinical Bacteriology), Argentinian Association of Microbiology].
    Famiglietti A; Quinteros M; Vázquez M; Marín M; Nicola F; Radice M; Galas M; Pasterán F; Bantar C; Casellas JM; Kovensky Pupko J; Couto E; Goldberg M; Lopardo H; Gutkind G; Soloaga R;
    Rev Argent Microbiol; 2005; 37(1):57-66. PubMed ID: 15991480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications].
    Schwarz S; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Traeder W; Waldmann KH; Wallmann J; Werckenthin C
    Berl Munch Tierarztl Wochenschr; 2003; 116(9-10):353-61. PubMed ID: 14526464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The external quality assessment for Mycobacterium tuberculosis drug susceptibility testing by proficiency testing panel to the commercial laboratories].
    Mitarai S;
    Kekkaku; 2005 Apr; 80(4):349-58. PubMed ID: 15991600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.
    Humphries RM; Hindler JA
    Clin Infect Dis; 2016 Jul; 63(1):83-8. PubMed ID: 27025822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge and practices of laboratory workers on standardized antimicrobial susceptibility testing and biosafety practices to prevent the spread of superbugs in Pakistan.
    Ghanchi NK; Khan E; Farooqi JQ; Fasih N; Dojki M; Hughes MA
    Am J Infect Control; 2014 Sep; 42(9):1022-4. PubMed ID: 25179341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How New Regulation of Laboratory-Developed Antimicrobial Susceptibility Tests Will Affect Infectious Diseases Clinical Practice.
    Wolfe KH; Pierce VM; Humphries RM
    Clin Infect Dis; 2024 May; 78(5):1140-1147. PubMed ID: 38573057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Areas of recent emphasis of the National Committee for Clinical Laboratory Standards Subcommittee on Antimicrobial Susceptibility Testing.
    Jorgensen JH
    Adv Exp Med Biol; 1994; 349():61-5. PubMed ID: 8209809
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimicrobic susceptibility testing. A personal perspective.
    Sherris JC
    Clin Lab Med; 1989 Jun; 9(2):191-202. PubMed ID: 2659240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FDA review criteria for assessment of antimicrobial susceptibility devices--too much or not enough regulation?
    Tomfohrde KM
    Adv Exp Med Biol; 1994; 349():135-43. PubMed ID: 8209799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.